Trial Profile
Phase 3 Clinical Study of Duloxetine Hydrochloride in Patients With CLBP - Open Label Long Term Extension Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Back pain
- Focus Adverse reactions; Registrational
- Sponsors Eli Lilly and Company
- 15 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Nov 2014 Planned End Date changed from 1 Feb 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 04 Nov 2014 Planned primary completion date changed from 1 Feb 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov.